GTAM
SER icon

Global Trust Asset Management’s Serina Therapeutics SER Stock Holding History

Global Trust Asset Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 442
2019
Q4 		$0 Hold
1
– – ﹤0.01% 431
2019
Q3 		$0 Hold
1
– – ﹤0.01% 449
2019
Q2 		$0 Hold
1
– – ﹤0.01% 455
2019
Q1 		$0 Buy
+1
New +$146 ﹤0.01% 457

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Global Trust Asset Management's SER Position: Q1 2020 in Review

Global Trust Asset Management sold out of Serina Therapeutics (SER) in Q1 2020, closing a stake of 1 share.

Global Trust Asset Management first reported a position in SER in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 49 funds tracked by Wall St. Rank hold SER as of Q1 2020.

  • Global Trust Asset Management reported no remaining Serina Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Global Trust Asset Management sold 1 Serina Therapeutics share in Q1 2020.
  • Global Trust Asset Management first reported a position in Serina Therapeutics in Q1 2019 and held it in 4 quarters.
  • Global Trust Asset Management's Serina Therapeutics position peaked at $0 in Q4 2019.
  • 49 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2020.

Based on Global Trust Asset Management's 13F filing for Q1 2020, filed 6 Apr 2020.